Aristacare At Manchester
ARISTACARE AT MANCHESTER in MANCHESTER, NJ — inspection on August 27, 2025.
Found 7 citations. Severity: Standard violations.
Health inspections identify deficiencies that facilities must correct within required timeframes. Violations range from minor documentation issues to serious safety concerns and are subject to follow-up verification.
Inspection Findings
Federal health inspectors cited ARISTACARE AT MANCHESTER in MANCHESTER, NJ for a deficiency under regulatory tag F-F0550 during a standard health inspection conducted on 2025-08-27.
Category: Resident Rights Deficiencies
The facility was found deficient in the following area: Honor the resident's right to a dignified existence, self-determination, communication, and to exercise his or her rights.
Scope/Severity Level D: isolated, no actual harm with potential for more than minimal harm.
While no actual harm was documented, there was potential for more than minimal harm to residents.
This was one of 7 deficiencies cited during this inspection of ARISTACARE AT MANCHESTER.
Correction Status: Deficient, Provider has date of correction.
The facility reported correction as of 2025-10-21.
Federal health inspectors cited ARISTACARE AT MANCHESTER in MANCHESTER, NJ for a deficiency under regulatory tag F-F0582 during a standard health inspection conducted on 2025-08-27.
Category: Resident Rights Deficiencies
The facility was found deficient in the following area: Give residents notice of Medicaid/Medicare coverage and potential liability for services not covered.
Scope/Severity Level D: isolated, no actual harm with potential for more than minimal harm.
While no actual harm was documented, there was potential for more than minimal harm to residents.
This was one of 7 deficiencies cited during this inspection of ARISTACARE AT MANCHESTER.
Correction Status: Deficient, Provider has date of correction.
The facility reported correction as of 2025-10-21.
Federal health inspectors cited ARISTACARE AT MANCHESTER in MANCHESTER, NJ for a deficiency under regulatory tag F-F0693 during a standard health inspection conducted on 2025-08-27.
Category: Quality of Life and Care Deficiencies
The facility was found deficient in the following area: Ensure that feeding tubes are not used unless there is a medical reason and the resident agrees; and provide appropriate care for a resident with a feeding tube.
Scope/Severity Level D: isolated, no actual harm with potential for more than minimal harm.
While no actual harm was documented, there was potential for more than minimal harm to residents.
This was one of 7 deficiencies cited during this inspection of ARISTACARE AT MANCHESTER.
Correction Status: Deficient, Provider has date of correction.
The facility reported correction as of 2025-10-21.
Federal health inspectors cited ARISTACARE AT MANCHESTER in MANCHESTER, NJ for a deficiency under regulatory tag F-F0761 during a standard health inspection conducted on 2025-08-27.
Category: Pharmacy Service Deficiencies
The facility was found deficient in the following area: Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted professional principles; and all drugs and biologicals must be stored in locked compartments, separately locked, compartments for controlled drugs.
Scope/Severity Level D: isolated, no actual harm with potential for more than minimal harm.
While no actual harm was documented, there was potential for more than minimal harm to residents.
This was one of 7 deficiencies cited during this inspection of ARISTACARE AT MANCHESTER.
Correction Status: Deficient, Provider has date of correction.
The facility reported correction as of 2025-10-21.
During an interview on 8/26/2025 at 1:48 AM with the surveyor the Director of Nursing, in the presence of the Licensed Nursing Home Administrator Regional Clinical Director acknowledged that the MAR/TAR should be completed in its entirety upon completion of the order and that if it was not filled in it could mean that the order was not done. A review the undated facility policy titled, Administering Medications revealed the following under Policy Interpretation and Implementation: [ .] 3.
Medications must be administered in accordance with the orders, including any required time frame. [ .] 11.
The individual administering the medication must document in [electronic records] after giving each medication by clicking the Y. [ .] 13. If a drug is withheld, refused, or given at a time other than the scheduled time, the individual administering the medication shall click the N on the EMAR and then document as prompted by PCC. A review the undated facility policy titled, Charting and Documentation revealed the following under Policy Interpretation and Implementation: 1.
All observations, medications administered, services performed, etc, must be documented in the resident's clinical record. NJAC 8:3923.2
Facility ID:
Federal health inspectors cited ARISTACARE AT MANCHESTER in MANCHESTER, NJ for a deficiency under regulatory tag F-F0880 during a standard health inspection conducted on 2025-08-27.
Category: Infection Control Deficiencies
The facility was found deficient in the following area: Provide and implement an infection prevention and control program.
Scope/Severity Level D: isolated, no actual harm with potential for more than minimal harm.
While no actual harm was documented, there was potential for more than minimal harm to residents.
This was one of 7 deficiencies cited during this inspection of ARISTACARE AT MANCHESTER.
Correction Status: Deficient, Provider has date of correction.
The facility reported correction as of 2025-10-21.
Federal health inspectors cited ARISTACARE AT MANCHESTER in MANCHESTER, NJ for a deficiency under regulatory tag F-F0882 during a standard health inspection conducted on 2025-08-27.
Category: Infection Control Deficiencies
The facility was found deficient in the following area: Designate a qualified infection preventionist to be responsible for the infection prevent and control program in the nursing home.
Scope/Severity Level D: isolated, no actual harm with potential for more than minimal harm.
While no actual harm was documented, there was potential for more than minimal harm to residents.
This was one of 7 deficiencies cited during this inspection of ARISTACARE AT MANCHESTER.
Correction Status: Deficient, Provider has date of correction.
The facility reported correction as of 2025-10-21.